Health

MedAlliance’s SELUTION SLR drug-eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval, making it the first limus DEB to be available to US patients

The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted “breakthrough device designation” by the FDA on March 4, 2019 and further in September 25, 2019 for below-the-knee (BTK) indications […]

thaipr.net

30 พ.ค. 65

UAE powerhouse VPS Healthcare launches Burjeel Holdings to scale the next generation of its growth

On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare services platform commits 50 pediatric stem cell transplantations to refugees of the Ukraine conflict The UAE-based VPS Healthcare has announced the launch of Burjeel Holdings on the sidelines of the World Economic Forum Annual Meeting in Davos on Sunday to consolidate […]

thaipr.net

27 พ.ค. 65

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent – No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned image along with […]

thaipr.net

24 พ.ค. 65

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8.19% in the ESR1 mutation population Data demonstrated elacestrant significantly reduced the risk of disease progression or […]

thaipr.net

23 พ.ค. 65
1 … 70 71 72 73 74 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.